Achromatopsia
12 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Gene Therapy for Achromatopsia (CNGA3) (NCT03758404) | MeiraGTx UK II Ltd | 2019-08-12 |
| Safety and Efficacy Trial of AAV Gene Therapy in Patients With CNGA3 Achromatopsia (A Clarity Clinical Trial) (NCT02935517) | Beacon Therapeutics | 2017-08-03 |
| Long-Term Follow-Up Gene Therapy Study for Achromatopsia CNGB3 and CNGA3 (NCT03278873) | MeiraGTx UK II Ltd | 2017-06-29 |
| Gene Therapy for Achromatopsia (CNGB3) (NCT03001310) | MeiraGTx UK II Ltd | 2017-01-16 |
| Safety and Efficacy Trial of AAV Gene Therapy in Patients With CNGB3 Achromatopsia (A Clarity Clinical Trial) (NCT02599922) | Beacon Therapeutics | 2016-04-11 |
| Inherited Retinal Degenerative Disease Registry (NCT02435940) | Foundation Fighting Blindness | 2014-06-01 |
| Clinical and Genetic Characterization of Individuals With Achromatopsia (NCT01846052) | Beacon Therapeutics | 2013-06-01 |
| CNTF Implants for CNGB3 Achromatopsia (NCT01648452) | National Eye Institute (NEI) | 2012-07-01 |
Track Achromatopsia automatically
Every clearance here is in the API, with alerts when new ones post.